In 2025, data protection is more important than ever. Yet, many in the pharma industry are still behind when it comes to ...

In today’s fast-paced experience economy, pharma companies can no longer rely on static displays and outdated engagement ...

Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and ...

Roche has announced that it will be advancing its Prothena-partnered investigational Parkinson’s disease (PD) drug ...

Novartis has shared positive results from a phase 3b study of Fabhalta (iptacopan) in a new population of patients with the ...